Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

S&P 500 Renews Climb as Merck's Covid Pill Soothes Bulls

Published 01/10/2021, 19:16
Updated 01/10/2021, 19:16

By Yasin Ebrahim

Investing.com – The S&P 500 rose sharply on Friday, as positive vaccine news prompted investors to renew their bullish bets on stocks following a sloppy September.

The S&P 500 rose 1%, the Dow Jones Industrial Average gained 1.3%, or 450 points, the Nasdaq was up 0.5%.

Merck & Company Inc (NYSE:MRK) reported that its experimental Covid-19 pills cut the risk of death and hospitalization by 50% in a study, sending its share price more than 9% higher.

The positive Covid-19 treatment news stoked investor optimism about the recovery amid an ongoing drag from the impact of the Delta variant.

Cyclical stocks including materials and energy took lead, with the latter helped expectations that energy prices will continue to climb to as high as $100 prices.

“If all these factors come together, oil prices could spike and lead to a second round of inflationary pressures around the world,” Bank of American said in a note.

Exxon Mobil (NYSE:XOM) was up 2% after raising its forecast on third-quarter earnings, citing higher oil and gas prices. The oil major said higher energy prices could boost earnings by as much as $1.5 billion.

Bets on reopening stocks – those that benefit from easing pandemic restrictions – renewed, with cruise and airlines companies leading the way.

United Airlines Holdings (NASDAQ:UAL), American Airlines Group (NASDAQ:NASDAQ:AAL), Carnival (NYSE:CUK) (NYSE:CCL) and Norwegian Cruise (NYSE:NCLH) were sharply higher.

Big tech, which fell victim to rising interest rates recently, traded mixed, with Apple and Amazon weighed down by concerns about ongoing supply-chain disruptions.  

Apple (NASDAQ:AAPL), an dAmazon.com (NASDAQ:AMZN) were in the red, while Facebook (NASDAQ:FB) and Alphabet (NASDAQ:GOOGL), and Microsoft (NASDAQ:MSFT) were higher.

On the economic front, the faster pace of inflation shows little sign of abating, but the consumer, which makes up about two-thirds of the economy, continues to spend.

The Federal Reserve's preferred inflation measure, the personal consumption expenditures (PCE) price index excluding food and energy, rose 1.3% in the 12 months through September.

Consumer spending in July rose by 0.8% month-on-month, from a 0.1% decline in the prior month.

“We remain constructive on consumer spending in the coming quarters. Even as the impulse from fiscal stimulus targeted at households fades, labor market  income and a savings cushion should support continued spending,” Morgan Stanley (NYSE:MS) said.

In Washington, meanwhile, House Speaker Nancy Pelosi was forced to delay a planned vote on the $1 trillion bipartisan infrastructure package amid ongoing wrangling within the Democratic caucus.

The House was hoping to pass the bipartisan infrastructure package and the $3.5 trillion reconciliation bill simultaneously, as part of a two-track strategy.

But Sen. Joe Manchin said he would support a reconciliation package worth only $1.5 trillion, well short of the proposed $3.5 trillion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.